Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
28.79
EUR
1.27%
Market Closed
Market Cap:
€1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
F
|
Fulton Financial Corp
F:FU5
|
US |
|
Banco Santander SA
F:BSDK
|
ES |
|
SPS Commerce Inc
F:S86
|
US |
|
DraftKings Inc
F:IK1
|
US |
|
D
|
Deckers Outdoor Corp
F:DO2
|
US |
|
L
|
Liaoning Port Co Ltd
F:D7P
|
CN |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
XMUN:BOY
|
ES |
|
E
|
eBay Inc
XBER:EBA
|
US |
|
G
|
Globant SA
F:2G2
|
LU |
|
S
|
Stock3 AG
F:BOG
|
DE |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
Wall St Price Targets
TCE2 Price Targets Summary
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Wall Street analysts forecast TCE2 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TCE2 is 37.44 EUR with a low forecast of 22.62 EUR and a high forecast of 62.24 EUR.
Lowest Forecast
Price Target
22.62
EUR
21% Downside
Average Forecast
Price Target
37.44
EUR
30% Upside
Highest Forecast
Price Target
62.24
EUR
116% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TCE2's stock price target?
Price Target
37.44
EUR
37.44
EUR
According to Wall Street analysts, the average 1-year price target for TCE2 is 37.44 EUR with a low forecast of 22.62 EUR and a high forecast of 62.24 EUR.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 14 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 147%.
